| __timestamp | Summit Therapeutics Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 15635076 | 242549000 |
| Thursday, January 1, 2015 | 23943601 | 245098000 |
| Friday, January 1, 2016 | 23689111 | 147600000 |
| Sunday, January 1, 2017 | 41006114 | 264600000 |
| Monday, January 1, 2018 | 51379106 | 357900000 |
| Tuesday, January 1, 2019 | 32705593 | 1182600000 |
| Wednesday, January 1, 2020 | 53274000 | 357700000 |
| Friday, January 1, 2021 | 85352000 | 540100000 |
| Saturday, January 1, 2022 | 51999000 | 322900000 |
| Sunday, January 1, 2023 | 59471000 | 408000000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and Summit Therapeutics Inc. have demonstrated contrasting strategies in their R&D investments.
United Therapeutics, a leader in the field, has consistently outpaced Summit Therapeutics, with R&D expenses peaking at nearly 1.2 billion in 2019. This represents a staggering 400% increase compared to Summit's highest expenditure in 2021. Despite Summit's more modest spending, their R&D expenses have shown a steady upward trend, growing by approximately 280% from 2014 to 2023.
These figures highlight the diverse approaches within the biotech sector, where larger firms like United Therapeutics leverage substantial R&D budgets to maintain their competitive edge, while smaller companies like Summit focus on strategic, incremental growth.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Summit Therapeutics Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Research and Development Expenses Breakdown: Alnylam Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
United Therapeutics Corporation vs Exelixis, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: United Therapeutics Corporation vs Xenon Pharmaceuticals Inc.
United Therapeutics Corporation vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Veracyte, Inc.
Summit Therapeutics Inc. vs Exelixis, Inc.: Strategic Focus on R&D Spending
Summit Therapeutics Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Taro Pharmaceutical Industries Ltd.